Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ATM, automatic, boost, bound, burn, buy, captured, carefully, certainty, cleaning, concert, consortium, contest, convene, corroborate, Cosmetic, COVID, CRL, culture, cyber, death, deep, defective, detention, diagnosed, distancing, distract, economy, endeavor, ESPP, expert, filling, frequency, furlough, GCP, geography, GLP, GMP, greatly, home, impossible, infrequently, inseverability, inseverable, intermediate, interval, lesser, magnitude, mentorship, mission, NrtI, opportunity, orderly, outsource, outsourced, oversee, pandemic, payout, payroll, penalized, percentile, Philosophy, phishing, plasma, plateau, PREA, prepaid, protease, PTAB, purity, quantifiable, quarantine, recapitalization, recapitalized, reconsent, rescind, salary, sanitation, satisfactorily, Science, screening, seat, shipment, silence, singular, society, spread, striving, sublicensee, Switching, talent, therefrom, Today, transcriptase, twenty, undeniable, unpatentable, unquantifiable, untitled, vacated, VBR, vebicorvir, verification, vigorously, week
Removed:
accelerate, accessible, adjustment, Agricultural, aimed, allegedly, amortize, analyst, anticancer, assumption, attribution, bank, burden, calculating, certificate, characterization, circumvention, clear, Codification, comparing, concentrated, conjunction, counterclaim, credited, CTA, declare, dedicated, deposit, derivative, directing, discovering, district, divided, downgrade, durable, earn, environment, equivalent, exacerbate, expiring, extremely, flexibility, hearing, hematology, high, improved, inappropriate, inhibition, insider, intensely, Interbank, investor, knockdown, leading, LIBOR, loan, London, lymphoma, MOA, Monsanto, moving, nominating, objective, offered, originally, overriding, PADCo, partial, perception, phased, PK, post, power, professional, promissory, proportion, publicly, publish, pursuing, rapid, reinvest, relate, release, relocation, replacement, reputable, restricted, retrospectively, secured, selective, showed, SOC, sublicense, suffering, surrendered, suspended, TCJA, terminating, tested, titled, Toronto, traded, trading, Trump, unaudited, unchanged, uneconomical, unexercised, unqualified, unrelated, unspecified, varying, visibility, vitro, vivo, voluntarily, volunteer, voting, waive, web, worked, workforce, write, wrongly
Filing tables
Filing exhibits
Related press release
Associated ABUS transcripts
ABUS similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report of Arbutus Biopharma Corporation (the “Company”) on Form 10-K for the year ended December 31, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I William Collier, President and Chief Executive Officer of the Company, certify that to the best of my knowledge:
1.The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of the operations of the Company.
Date: March 4, 2021
/s/ William Collier | |||||||||||
Name: | William Collier | ||||||||||
Title: | President and Chief Executive Officer | ||||||||||
(Principal Executive Officer) |